<SEC-DOCUMENT>0001104659-21-100801.txt : 20210805
<SEC-HEADER>0001104659-21-100801.hdr.sgml : 20210805
<ACCEPTANCE-DATETIME>20210805163630
ACCESSION NUMBER:		0001104659-21-100801
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20210801
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210805
DATE AS OF CHANGE:		20210805

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Immunome Inc.
		CENTRAL INDEX KEY:			0001472012
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770694340
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39580
		FILM NUMBER:		211148955

	BUSINESS ADDRESS:	
		STREET 1:		665 STOCKTON DRIVE
		STREET 2:		SUITE 300
		CITY:			EXTON
		STATE:			PA
		ZIP:			19341
		BUSINESS PHONE:		610-321-3700

	MAIL ADDRESS:	
		STREET 1:		665 STOCKTON DRIVE
		STREET 2:		SUITE 300
		CITY:			EXTON
		STATE:			PA
		ZIP:			19341
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2124229d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:immu="http://immunome.com/20210801">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_immu_immunome.com_20210801 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20210801_20210801 -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0001472012 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-08-01to2021-08-01" name="dei:EntityCentralIndexKey">0001472012</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-08-01to2021-08-01" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="immu-20210801.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-08-01to2021-08-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001472012</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-01</xbrli:startDate>
        <xbrli:endDate>2021-08-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 13.5pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 13.5pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"></span>&#160;</p>

<p style="font: 13.5pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 18pt"><b>UNITED STATES </b></span></p>

<p style="font: 13.5pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 18pt"><b>SECURITIES AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>Washington, D.C. 20549 </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 18pt"><b>FORM <span id="xdx_904_edei--DocumentType_c20210801__20210801_zxNPJMQNRcU5"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>CURRENT REPORT </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) <br /> of the Securities Exchange Act of 1934 </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_903_edei--DocumentPeriodEndDate_c20210801__20210801_zXFNNb9Mm061"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">August 1, 2021</ix:nonNumeric></span></b>&#160;</p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_907_edei--EntityRegistrantName_c20210801__20210801_zEUdXF685MEg"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" name="dei:EntityRegistrantName">Immunome, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in its charter)</b>&#160;</p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-left: auto; margin-right: auto">
<tr>
<td style="vertical-align: bottom; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20210801__20210801_zH7tVCxuhtS2"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
<td style="vertical-align: top; text-align: center; width: 2%">&#160;</td>
<td style="vertical-align: bottom; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_90F_edei--EntityFileNumber_c20210801__20210801_zeDVEN0EoYt1"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" name="dei:EntityFileNumber">001-39580</ix:nonNumeric></span></b></span></td>
<td style="vertical-align: top; text-align: center; width: 2%">&#160;</td>
<td style="vertical-align: bottom; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20210801__20210801_zsHtPQ7B0ZH3"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" name="dei:EntityTaxIdentificationNumber">77-0694340</ix:nonNumeric></span></b></span></td></tr>
<tr>
<td style="vertical-align: top; text-align: center"><b>(state or other jurisdiction <br /> of incorporation)</b></td>
<td style="vertical-align: top; text-align: center"><b>&#160;</b></td>
<td style="vertical-align: top; text-align: center"><b>(Commission <br /> File Number)&#160;</b></td>
<td style="vertical-align: top; text-align: center"><b>&#160;</b></td>
<td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>(I.R.S. Employer <br /> Identification No.)</b></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: auto; margin-right: auto">
<tr style="vertical-align: top">
<td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 49%; text-align: center"><b><span id="xdx_90F_edei--EntityAddressAddressLine1_c20210801__20210801_zea32GNT5jrl"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" name="dei:EntityAddressAddressLine1">665 Stockton Drive, Suite 300</ix:nonNumeric></span></b> <b><br />
<span id="xdx_90E_edei--EntityAddressCityOrTown_c20210801__20210801_zV390CFSc4Cf"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" name="dei:EntityAddressCityOrTown">Exton</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressStateOrProvince_c20210801__20210801_zcPkW5tJnEOe"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Pennsylvania</ix:nonNumeric></span></b></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 2%">&#160;</td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 49%; text-align: center; vertical-align: bottom"><b><span id="xdx_905_edei--EntityAddressPostalZipCode_c20210801__20210801_zKm3oc2unU4f"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" name="dei:EntityAddressPostalZipCode">19341</ix:nonNumeric></span></b></td></tr>
<tr style="vertical-align: top">
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>(Address of principal executive offices) &#160;</b></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>&#160;</b></td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>(Zip Code)</b></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Registrant&#8217;s telephone number, including area code: (<span id="xdx_901_edei--CityAreaCode_c20210801__20210801_zl8MHBnpOTYg"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" name="dei:CityAreaCode">610</ix:nonNumeric></span></b></span><b><span style="font-family: Times New Roman, Times, Serif">) <span id="xdx_904_edei--LocalPhoneNumber_c20210801__20210801_zqdc9Of7Y7t7"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" name="dei:LocalPhoneNumber">321-3700</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Not applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>(Former name or former address, if changed since last report.)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_904_edei--WrittenCommunications_c20210801__20210801_zACnqyOUSgvl"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_907_edei--SolicitingMaterial_c20210801__20210801_z5tSLj6pKgt5"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90F_edei--PreCommencementTenderOffer_c20210801__20210801_z7qwHbHfwY04"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_905_edei--PreCommencementIssuerTenderOffer_c20210801__20210801_zcncNCzA6DPf"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Title of each class</span></td>
    <td style="padding-bottom: 1pt; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Trading Symbol</span></td>
    <td style="padding-bottom: 1pt; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Name
    of each exchange on which registered</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span id="xdx_90A_edei--Security12bTitle_c20210801__20210801_zeCiQgFW2UE6" style="font: 10pt Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" name="dei:Security12bTitle">Common
    Stock, $0.0001 par value per share</ix:nonNumeric> </b></span></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><span id="xdx_90B_edei--TradingSymbol_c20210801__20210801_zFMA3OsEoT15" style="font: 10pt Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" name="dei:TradingSymbol">IMNM</ix:nonNumeric></b></span></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>The <span id="xdx_90E_edei--SecurityExchangeName_c20210801__20210801_z27rR1WWHbn2"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</b></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0in">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). <span style="font-family: Wingdings"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-indent: 0.5in">Emerging growth company&#160;<span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_905_edei--EntityEmergingGrowthCompany_c20210801__20210801_z02IjCScuo54"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#120;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0in">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90E_edei--EntityExTransitionPeriod_c20210801__20210801_zfi4aApAgqN2"><ix:nonNumeric contextRef="From2021-08-01to2021-08-01" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 1in"><b>Item 5.02.</b></td>
    <td style="text-align: justify"><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 1, 2021, Immunome, Inc. (the &#8220;Company&#8221;) and Michael
J. Morin, Ph.D. entered into a Second Amended and Restated Employment Agreement (the &#8220;Employment Agreement&#8221;), which amended
and superseded the Amended and Restated Employment Agreement between the Company and Dr. Morin dated September 24, 2020 (the &#8220;Original
Agreement&#8221;). In connection with the execution and delivery of the Employment Agreement, Dr. Morin resigned from his positions as
Chief Scientific Officer and Executive Vice President of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Employment Agreement, Dr. Morin will be employed by
the Company on a part-time basis as its Chief Scientist. In his new role, Dr.&#160;Morin is entitled to an initial annual base salary
of $60,000. The Employment Agreement also provides for a bonus opportunity for the portion of calendar year 2021 during which Dr. Morin
served as Chief Scientific Officer, entitlement to which is subject to achievement of individual and Company-wide performance goals.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accelerated vesting provisions of the Original Agreement related
to Dr. Morin&#8217;s equity in connection with certain termination events remain unchanged in the Employment Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing description of the Employment Agreement is not complete
and is qualified in its entirety by reference to the full text of the Employment Agreement, a copy of which is filed as Exhibit 10.1 to
this Current Report on Form 8-K and is incorporated by reference herein.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 96px"><span style="font-size: 10pt"><b>Item 9.01</b></span></td>
    <td><span style="font-size: 10pt"><b>Financial Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; width: 5%"><span style="font-size: 10pt"><b>Exhibit</b> <br />
<b>No.</b></span></td>
    <td style="padding: 0.25pt 0.25pt 1.25pt; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; width: 94%"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><a href="tm2124229d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.1</span></a></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: top"><a href="tm2124229d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Second Amended and Restated Employment Agreement, dated August 1, 2021, by and between the Company and Dr. Morin</span></a></td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 10pt">104</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt"><span style="font-size: 10pt"><b>IMMUNOME,&#160;INC.</b></span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; width: 50%">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: top; width: 3%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; padding: 0.25pt; vertical-align: bottom; width: 47%"><span style="font-size: 10pt">/s/ Purnanand D. Sarma, Ph.D.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: top">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Purnanand D. Sarma, Ph.D.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">President and Chief Executive Officer</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: August 5, 2021</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LNoNVNybDhVxiowhvhYXpbg1I63TfZJ/abchhkBIbs69QozElja6RIbLKkshx6oulUPI8IaM5or+I9ntY/Azw7u2jpVx/foDE/IMemY6Dq/+3n822mIRQxhN5GISLkDOYjmH5UEEnZ6QuekCjdOqBGUKODHVrNEpbgeHXL3JUNX2SWdkq8l4u7Ec5A9EMozgSI16ET8spGkiglFfgdgyPesu5mkdVbAusfJZdkD/HXwB2llJEw== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2124229d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><B>Exhibit
10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECOND AMENDED AND RESTATED
EMPLOYMENT AGREEMENT</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt; text-align: justify; text-indent: 0.5in">This
SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the &ldquo;<B><I>Agreement</I></B>&rdquo;) is entered into effective as of August 1,
2021 (the &ldquo;<B><I>Effective Date</I></B>&rdquo;), by and between Michael J. Morin, Ph.D. (&ldquo;<B><I>Executive</I></B>&rdquo;)
and Immunome, Inc. (the &ldquo;<B><I>Company</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7pt; text-align: justify; text-indent: 33.7pt; color: #252525">Executive
is employed by the Company as its Executive Vice President and Chief Scientific Officer pursuant to an amended and restated employment
agreement with the Company effective on October 6, 2020 (the <B><I>&ldquo;Prior Agreement&rdquo;</I></B><I>)</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.1pt; text-align: justify; text-indent: 34.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #252525">The
Company and Executive have mutually agreed to amend certain terms governing the employment of Executive and, </FONT><FONT STYLE="color: #424242">i</FONT><FONT STYLE="color: #252525">n
connection therewith, to compensate Executive for Executive&rsquo;s personal services to the Company as stated below; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.1pt; text-align: justify; text-indent: 34.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #252525">Executive
wishes to continue to be employed by the Company and provide personal services to the Company in return for certain compensation, all
on the basis specified below</FONT><FONT STYLE="color: #424242">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.45pt; text-align: justify; text-indent: 33.9pt; color: #252525">Accordingly,
in consideration of the mutual promises and covenants contained herein, the parties agree to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #202020"><TR STYLE="vertical-align: top">
<TD STYLE="width: 41.75pt"></TD><TD STYLE="width: 33.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>1.</B></FONT></TD><TD STYLE="text-align: left"><B><U>EMPLOYMENT
                                            BY THE COMPANY.</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 6.95pt; text-align: justify; text-indent: 68.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #252525"><B>1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="color: #252525"><U>At-Will Employment.</U></FONT></B><FONT STYLE="color: #252525"> E</FONT><FONT STYLE="color: #424242">x</FONT><FONT STYLE="color: #252525">ecutive
shall continue to be employed by the Company on an &ldquo;at-will&rdquo; basis</FONT><FONT STYLE="color: #424242">, </FONT><FONT STYLE="color: #252525">meaning
either the Company or Executive may terminate Executive&rsquo;s employment at any time</FONT><FONT STYLE="color: #424242">, </FONT><FONT STYLE="color: #252525">with
or without Cause (as defined in Section 6</FONT><FONT STYLE="color: #424242">.</FONT><FONT STYLE="color: #252525">2(e) below), Good Reason
(as defined in Section 6.2(d) below), or advance notice</FONT><FONT STYLE="color: #424242">.</FONT> <FONT STYLE="color: #252525">Any contrary
representations that may have been made to Executive shall be superseded by this Agreement. This Agreement shall constitute the full
and complete agreement between Executive and the Company on the &ldquo;at-will&rdquo; nature of Executive&rsquo;s employment with the
Company, which may be changed only in an express written agreement signed by Executive and a duly authorized officer of the Company.
Executive&rsquo;s rights to any compensation following a termination shall be only as set forth in Section 6 or under any applicable
benefit or equity plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 6.95pt; text-align: justify; text-indent: 68.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #252525"><B>1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="color: #252525"><U>Position.</U></FONT></B><FONT STYLE="color: #252525"> Subject to the terms set forth in
this Agreement, including Section 1.1, the Company agrees to continue to employ Executive and Executive hereby accepts such continued
employment. In addition, Executive shall have the title of Chief Scientist. Executive will work the equivalent of 25% of a full</FONT><FONT STYLE="color: #424242">-</FONT><FONT STYLE="color: #252525">time
schedule, which typically will equate to five (5) days per month devoted to Executive&rsquo;s work for the Company (the <B><I>&ldquo;Part-Time
Schedule&rdquo;</I></B><I>). </I>During the schedule established by the Company and the Executive in accordance with Executive&rsquo;s
Part-Time Schedule, and excluding periods of paid time off to which Executive is entitled under applicable law, Executive shall devote
all business time and attention to the affairs of the Company necessary to discharge the responsibilities assigned hereunder, and shall
use commercially reasonable efforts to perform faithfully and efficiently such responsibilities</FONT><FONT STYLE="color: #424242">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 6.95pt; text-align: justify; text-indent: 68.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #252525"><B>1.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="color: #252525"><U>Duties</U></FONT><FONT STYLE="color: #424242">. </FONT></B><FONT STYLE="color: #252525">Executive
will report to the Chief Development Officer and will render the services listed on Exhibit A and such additional business and professional
services&rsquo;, consistent with Executive&rsquo;s position as Chief Scientist, as shall </FONT><FONT STYLE="color: #202020">reasonably
be assigned to him, subject to the oversight and direction of the Chief Development Officer</FONT><FONT STYLE="color: #050505">.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.55pt; text-align: justify; text-indent: 68.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.55pt; text-align: justify; text-indent: 68.15pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.55pt; text-align: justify; text-indent: 68.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.55pt; text-align: justify; text-indent: 68.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #202020"><B>1.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="font-size: 10pt; color: #202020"><U>Location.</U></FONT></B> <FONT STYLE="color: #202020">Executive shall perform
Executive&rsquo;s duties under this Agreement principally out of his home office. However, Executive shall from time to time as mutually
agreed by Executive and the Company work out of the Company&rsquo;s corporate headquarters in Exton, Pennsylvania. In addition, Executive
shall make such business trips to such places as may be reasonably necessary or advisable for the efficient operations of the Company
and the implementation of its strategic plans</FONT><FONT STYLE="color: #050505">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.55pt; text-align: justify; text-indent: 68.15pt"><FONT STYLE="color: #050505">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.35pt; text-align: justify; text-indent: 68.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #202020"><B>1.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="font-size: 10pt; color: #202020"><U>Company Policies and Benefits</U></FONT></B><B><FONT STYLE="font-size: 10pt; color: #050505">.
</FONT></B><FONT STYLE="color: #202020">The employment relationship between the parties shall continue to be subject to the Company&rsquo;s
written personnel policies and procedures as they may be adopted, revised, or deleted from time to time in the Company&rsquo;s sole discretion
</FONT><FONT STYLE="color: #050505">.</FONT> <FONT STYLE="color: #202020">Executive shall be expected to continue to comply with all applicable
laws, regulations, rules, directives and other legal requirements of federal, state and other governmental and regulatory bodies having
jurisdiction over the Company and of the professional bodies of which the Company is a member. During Executive&rsquo;s employment with
the Company, Executive continues to be required to maintain in good standing any licenses and certifications necessary for the performance
of Executive&rsquo;s duties for the Company. Executive will continue to be eligible to participate on the same basis as similarly- situated
employees in the Company&rsquo;s benefit plans in effect from time to time during Executive&rsquo;s employment, subject, however, to
any additional eligibility limitations that may result from Executive&rsquo;s part-time status as a result of this Agreement. Subject
to the preceding sentence, the Company reserves the right to change, alter, or terminate any benefit plan in its sole discretion. All
matters of eligibility for coverage or benefits under any benefit plan shall be determined in accordance with the provisions of such
plan. Notwithstanding the foregoing, in the event that the terms of this Agreement differ from or are in conflict with the Company&rsquo;s
general employment policies or practices, this Agreement shall control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.35pt; text-align: justify; text-indent: 68.6pt"><FONT STYLE="color: #202020">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #202020"><TR STYLE="vertical-align: top">
<TD STYLE="width: 41.75pt"></TD><TD STYLE="width: 33.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.</B></FONT></TD><TD STYLE="text-align: left"><B><U>COMPENSATION.</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.7pt; text-align: justify; text-indent: 68.05pt; color: #202020"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</I></B></FONT><B><FONT STYLE="font-size: 10pt"><U>Salary</U>.</FONT></B> Commencing on the Effective Date, Executive shall receive an
annualized base salary of $60,000, subject to review and adjustment from time to time by the Company in its sole discretion, payable
subject to standard federal and state payroll withholding requirements in accordance with the Company&rsquo;s standard payroll practices
(the <B><I>&ldquo;Base Salary&rdquo;).</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 75.8pt"></TD><TD STYLE="width: 33.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #202020"><B>2.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: Black"><B><U>Bonus.</U></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.55pt; text-align: justify; text-indent: 101.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #252525"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><FONT STYLE="font-size: 10pt; color: #202020"><U>During Employment.</U></FONT> <FONT STYLE="color: #202020">Executive&rsquo;s
service as Chief Scientific Officer of the Company from January 1, 2021 through July 31, 2021 (the &ldquo;<B><I>Prior Period</I></B>&rdquo;)
is hereby acknowledged. Accordingly, Executive shall be eligible to receive a performance bonus (the <B><I>&ldquo;Prior Period Bonus&rdquo;</I></B>)
with a target of up to 40% (the <B><I>&ldquo;Target Percentage&rdquo;</I></B>) of Executive&rsquo;s annual base salary immediately prior
to the date of this Agreement; provided, that any amount of the Prior Period Bonus shall be pro rated for the Prior Period, so as to
take into account only the portion of calendar year 2021 during which Executive served as Chief Scientific Officer of the Company (i.e.,
58.33%, or seven out of 12 months). In addition, whether, and to what extent, the Prior Period Bonus will be earned will be based upon
the</FONT> <FONT STYLE="color: #252525">assessment of the Board of Directors of the Company (the <B><I>&ldquo;Board&rdquo;</I></B>) (or
a committee thereof) of both Executive&rsquo;s individual performance during the Prior Period and the Company&rsquo;s attainment of targeted
goals (as set by the Company and confirmed by the Board) over calendar year 2021. The Prior Period Bonus, if any, will be subject to
applicable payroll deductions and withholdings. No amount of any Prior Period Bonus is guaranteed at any time, and Executive must be
an employee in good standing through the date the Prior Period Bonus is paid to be eligible to receive a Prior Period Bonus</FONT><FONT STYLE="color: #070707">.
</FONT><FONT STYLE="color: #252525">Any Prior Period Bonus, if awarded, will be paid at the same time annual bonuses are generally paid
to other <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">similarly-situated employees of the Company</FONT></FONT><FONT STYLE="color: #444444">.
</FONT><FONT STYLE="color: #252525">Executive&rsquo;s eligibility for a Prior Period Bonus is subject to change in the discretion of
the Board (or any authorized committee thereof). Executive acknowledges that the Prior Period Bonus opportunity is in lieu of any bonus
opportunity contemplated by the Original Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.55pt; text-align: justify; text-indent: 101.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #252525"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="font-size: 10pt; color: #252525"><U>Upon Termination </U></FONT></B><B><FONT STYLE="font-size: 10pt; color: #444444">.
</FONT></B><FONT STYLE="color: #444444">I</FONT><FONT STYLE="color: #252525">n the event Executive leaves the employ of the Company for
any reason prior to the date that any Prior Period Bonus is paid, Executive is not eligible to earn such Prior Period Bonus, prorated
or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.45pt; text-align: justify; text-indent: 68.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #252525"><B>2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="font-size: 10pt; color: #252525"><U>Company Equity Awards</U></FONT></B><B><FONT STYLE="font-size: 10pt; color: #444444">.
</FONT></B><FONT STYLE="color: #444444; font-size: 10pt">For the avoidance of doubt, vesting of any and all unvested equity awards shall
continue in accordance with the terms of the respective grant agreements, and the termination of the Prior Agreement and execution and
delivery of this Agreement shall not, in and of itself, constitute a termination of service under such grant agreements</FONT><FONT STYLE="color: #252525">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #252525"><TR STYLE="vertical-align: top">
<TD STYLE="width: 75.55pt"></TD><TD STYLE="width: 33.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.4</B></FONT></TD><TD STYLE="text-align: justify"><B><U>Expense
                                            Reimbursement</U>.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.95pt; text-align: justify; text-indent: 101.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #252525"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="font-size: 10pt; color: #252525"><U>Generally</U></FONT></B><B><FONT STYLE="font-size: 10pt; color: #444444">.
</FONT></B><FONT STYLE="color: #252525">The Company will reimburse Executive for reasonable business expenses in accordance with the
Company&rsquo;s standard expense reimbursement policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.55pt; text-align: justify; text-indent: 102.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #252525"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="font-size: 10pt; color: #252525"><U>Travel and Lodging Expenses.</U></FONT></B> <FONT STYLE="color: #252525">The
Company will pay directly or reimburse Executive&rsquo;s reasonable out-of-pocket costs of commuting to Exton, Pennsylvania from Salisbury,
Massachusetts (to the extent that such expenses are reasonably documented and submitted to the Company for reimbursement promptly after
they are incurred)</FONT><FONT STYLE="color: #444444">. </FONT><FONT STYLE="color: #252525">Such expenses will include</FONT><FONT STYLE="color: #444444">,
</FONT><FONT STYLE="color: #252525">without limitation, reasonable, out of pocket costs for coach airfare, hotel/temporary accommodation
(or accommodation in the Company&rsquo;s corporate apartment), and car rental/other transportation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.8pt; text-align: justify; text-indent: 101.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #252525"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="color: #252525"><U>Payment.</U></FONT></B><FONT STYLE="color: #252525"> With respect to any such reimbursements
hereunder: (a) any such reimbursements will be paid no later than December 31 of the year following the year in which the expense was
incurred, (b) the amount of expenses reimbursed in one year will not affect the amount eligible for reimbursement in any subsequent year,
(c) the right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit</FONT><FONT STYLE="color: #444444">,
</FONT><FONT STYLE="color: #252525">and (d) the Company shall have the right to deduct from all payments hereunder any taxes required
by law to be withheld with respect to any such reimbursement payments.</FONT></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9.6pt; text-align: justify; text-indent: 67pt; color: #282525"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><FONT STYLE="font-size: 10pt; color: #252525"><U>CONFIDENTIAL
INFORMATION, INVENTIONS, NON-SOLICITATION AND NON- COMPETITION OBLIGATIONS.</U></FONT></B> <FONT STYLE="color: #252525">In connection
with Executive&rsquo;s continued employment with the Company, Executive will continue to receive and continue to have access to the Company&rsquo;s
confidential information and trade secrets</FONT><FONT STYLE="color: #070707">. </FONT><FONT STYLE="color: #252525">Accordingly, and
in consideration of the benefits that Executive is eligible to receive under this Agreement, Executive agrees to sign the Company&rsquo;s
Employee Confidential Information and Inventions Assignment Agreement (the <B><I>&ldquo;Confidential Information Agreement&rsquo;), </I></B>attached
as <FONT STYLE="font-size: 10pt"><B><U>Exhibit B,</U></B></FONT> which contains certain confidentiality, non- disclosure, non-solicitation
and non-competition obligations, among other obligations. The</FONT> <FONT STYLE="font-size: 10pt; color: #282525">Confidential Information
Agreement contains provisions that are intended by the parties to survive and do survive termination or expiration of this Agreement
and will supersede, prospectively only, the agreement that Executive previously signed relating to the same subject matter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9.6pt; text-align: justify; text-indent: 67pt; color: #282525"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><U>OUTSIDE ACTIVITIES.</U></B> Except with the prior written consent of the Board, Executive will not, while employed by
the Company, undertake or engage in any other employment, occupation, <FONT STYLE="font-family: Times New Roman, Times, Serif; color: #282525">or
business enterprise except for (i) reasonable time devoted to volunteer services for or on behalf of such religious, educational, non-profit,
and/or other charitable organization as Executive may wish to serve, (ii) reasonable time devoted to activities in the non-profit and
business communities consistent with Executive&rsquo;s position with the Company, (iii) fulfilling speaking engagements and teaching
activities, and (iv) such other activities as may be specifically approved by the Board, to include those listed on <B><U>Exhibit C,
</U></B>in the cases of (i)-(iv), so long as such activities do not materially interfere or conflict with the performance of Executive&rsquo;s
duties and responsibilities under this Agreement. This restriction shall not, however, preclude Executive from (x) owning less than one
percent (1%) of the total outstanding shares of a publicly-traded company, (y) managing Executive&rsquo;s passive personal investments,
or (z) employment or service in any capacity with Affiliates of the Company. As used in this Agreement, <B><I>&ldquo;Affiliates&rdquo;
</I></B>means, at the time of determination, any &ldquo;parent&rdquo; or &ldquo;subsidiary&rdquo; of the Company as such terms are defined
in Rule 405 of the Securities Act of 1933, as amended. The Board will have the authority to determine the time or times at which &ldquo;parent&rdquo;
or &ldquo;subsidiary&rdquo; status is determined within the foregoing definition</FONT> <FONT STYLE="color: #060606">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9.6pt; text-align: justify; text-indent: 67pt; color: #282525"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #282525"><B>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="color: #282525"><U>No CONFLICT WITH EXISTING OBLIGATIONS.</U></FONT></B><FONT STYLE="color: #282525"> Executive
represents that Executive&rsquo;s performance of all the terms of this Agreement and continued service as an employee of the Company
do not and will not breach any agreement or obligation of any kind made prior to Executive&rsquo;s employment by the Company, including
agreements or obligations Executive may have with prior employers or entities for which Executive has provided services</FONT><FONT STYLE="color: #4a4a4a">.
</FONT><FONT STYLE="color: #282525">Executive has not entered into, and Executive agrees that Executive will not enter into, any agreement
or obligation, either written or oral, in conflict herewith or with Executive&rsquo;s duties to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9.6pt; text-align: justify; text-indent: 67pt; color: #282525"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><U>TERMINATION OF EMPLOYMENT.</U></B> The parties acknowledge that Executive&rsquo;s employment relationship with the Company
continues to be at-will. Either Executive or the Company may terminate the employment relationship at any time, with or without Cause
(as defined below) or advance notice. The provisions in this Section govern the amount of compensation, if any, to be provided to Executive
upon termination of employment and do not alter this at-will status.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #282525"><TR STYLE="vertical-align: top">
<TD STYLE="width: 77.95pt"></TD><TD STYLE="width: 33.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>6.1</B></FONT></TD><TD STYLE="text-align: justify"><B><U>Termination
                                            by Virtue of Death or Disability of Executive.</U></B></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 10.2pt; text-align: justify; text-indent: 101.75pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>In the event of Executive&rsquo;s death while employed pursuant to this Agreement, all obligations of the parties hereunder and Executive&rsquo;s
employment shall terminate immediately, and the Company shall, pursuant to the Company&rsquo;s standard payroll policies and applicable
law, pay to Executive&rsquo;s legal representatives the Accrued Obligations (as defined in Section 6.2(c) below) due to Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 10.2pt; text-align: justify; text-indent: 101.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><FONT STYLE="color: #282525">Subject to applicable state and federal law, the Company shall at all times have the right, upon
written notice to Executive, to terminate this Agreement based on Executive&rsquo;s Disability (as defined below)</FONT><FONT STYLE="color: #060606">.
</FONT><FONT STYLE="color: #282525">Termination by the Company of Executive&rsquo;s employment </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #282828">based
on <B><I>&ldquo;Disability&rdquo; </I></B>shall mean termination because Executive is unable due to a physical or mental condition to
perform the essential functions of Executive&rsquo;s position with or without reasonable accommodation for six (6) months in the aggregate
during any twelve (12) month period or based on the written certification by two licensed physicians of the likely continuation of such
condition for such period. This definition shall be interpreted and applied consistent with the Americans with Disabilities Act, the
Family and Medical Leave Act, and other applicable law. In the event Executive&rsquo;s employment is terminated based on Executive&rsquo;s
Disability, Executive will be entitled to the Accrued Obligations due to Executive</FONT><FONT STYLE="color: #525252">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 8.5pt; text-align: justify; text-indent: 0.5pt"><FONT STYLE="color: #525252">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 8.75pt; text-align: justify; text-indent: 102pt; color: #282828"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT>In the event Executive&rsquo;s employment is terminated based on Executive&rsquo;s death or Disability, Executive will not
receive the CIC Acceleration (as defined below), or any other severance compensation or benefit, except that the Company will provide
the Accrued Obligations (as stated in Sections 6.l(a) and 6. l(b )).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #282828"><TR STYLE="vertical-align: top">
<TD STYLE="width: 77.1pt"></TD><TD STYLE="width: 33.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>6.2</B></FONT></TD><TD STYLE="text-align: justify"><B><U>Termination
                                            by the Company or Resignation by Executive.</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt; text-align: justify; text-indent: 102pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #282828"><B><I>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</I></B></FONT><FONT STYLE="color: #282828">The Company shall have the right to terminate Executive&rsquo;s employment pursuant to this
Section 6.2 at any time (subject to any applicable cure period stated in Section 6.2(e)) with or without Cause or advance notice, by
giving notice as described in Section 7.1 of this Agreement. Likewise, Executive can resign from employment with or without Good Reason,
by giving notice as described in Section 7.1 of this Agreement. Executive hereby agrees to comply with the additional notice requirements
set forth in Section 6.2(d) below for any resignation for Good Reason. If Executive is terminated by the Company (with or without Cause)
or resigns from employment with the Company (with or without Good Reason), then Executive shall be entitled to the Accrued Obligations
(as defined below)</FONT><FONT STYLE="color: #525252">.</FONT> <FONT STYLE="color: #282828">In addition, if Executive is terminated without
Cause or resigns for Good Reason, in either case, within three (3) months prior to or within twelve (12) months following the effective
date of a Change in Control (as defined in the Company&rsquo;s 2020 Equity Incentive Plan, as may be amended from time to time) (such
period, the <B><I>&ldquo;Change in Control Measurement Period&rdquo;&lsquo;),</I></B> and provided that such termination constitutes
a &ldquo;separation from service&rdquo; (as defined under Treasury Regulation Section 1.409A-l(h), without regard to any alternative
definition thereunder, a <B><I>&ldquo;Separation from Service&rdquo;), </I></B>and further provided that Executive executes and allows
to become effective a separation agreement that includes, among other terms, a generalrelease of claims in favor of the Company and its
Affiliates and representatives, in the form presented by the Company (the <B><I>&ldquo;Separation Agreement&rsquo;), </I></B>which will
include a non-competition clause, and subject to Section 6.2(b), then, effective as of Executive&rsquo;s termination date or, if later,
the date of such Change in Control, the vesting and exercisability of all outstanding equity awards held by Executive immediately prior
to the termination date (if any) shall be accelerated in full (the <B><I>&ldquo;CIC Acceleration&rdquo;).</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9.5pt; text-align: justify; text-indent: 101.95pt; color: #282828"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT>Executive shall not receive the CIC Acceleration pursuant to Section 6.2(a) unless Executive executes the Separation Agreement
within the consideration period specified therein, which shall in no event be more than forty-five (45) days, and until the Separation
Agreement becomes effective and can no longer be revoked by Executive under its terms. Executive&rsquo;s ability to receive the CIC Acceleration
pursuant to Section 6.2(a) is further conditioned upon Executive: (i) returning all Company property; (ii) complying with Executive&rsquo;s
post- termination obligations under this Agreement and the Confidential Information Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9.5pt; text-align: justify; text-indent: 101.95pt; color: #282828">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9.5pt; text-align: justify; text-indent: 101.95pt; color: #282828"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9.5pt; text-align: justify; text-indent: 101.95pt; color: #282828">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #282828"><TR STYLE="vertical-align: top">
<TD STYLE="width: 9.8pt"></TD><TD STYLE="width: 19.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify">complying
                                            with the Separation Agreement, including without limitation any non-disparagement <FONT STYLE="font-family: Times New Roman, Times, Serif">and
                                            confidentiality prov1s10ns contained therein; and (iv) resignation from any other positions
                                            </FONT>Executive holds with the Company, effective no later than Executive&rsquo;s date of
                                            termination (or such other date as requested by the Board).
</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt; text-align: justify; text-indent: 103.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #222222"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><FONT STYLE="font-size: 10pt; color: #222222">For purposes of this Agreement,</FONT> <FONT STYLE="color: #222222"><B><I>&ldquo;Accrued
Obligations&rdquo;</I></B> <FONT STYLE="font-size: 10pt">are (i) Executive&rsquo;s accrued but unpaid salary through the date of termination,
(ii) any unreimbursed business expenses incurred by Executive payable in accordance with the Company&rsquo;s standard expense reimbursement
policies, and (iii) benefits owed to Executive under any qualified retirement plan or health and welfare benefit plan in which Executive
was a participant in accordance with applicable law and the provisions of such plan</FONT></FONT><FONT STYLE="font-size: 10pt; color: #050505">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt; text-align: justify; text-indent: 103.55pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><FONT STYLE="font-size: 10pt">For purposes of this Agreement,</FONT> <B><I>&ldquo;Good Reason&rdquo;</I></B> <FONT STYLE="font-size: 10pt">means
any of the following actions taken by the Company without Executive&rsquo;s express prior written consent: (i) a material reduction by
the Company of Executive&rsquo;s Base Salary (other than in a broad based reduction similarly affecting all other similarly situated
employees&rsquo;); or (ii) a material reduction in Executive&rsquo;s duties, authority, or responsibilities for the Company relative
to Executive&rsquo;s duties, authority, or responsibilities in effect immediately prior to such reduction, provided, however, that neither
the conversion of the Company to a subsidiary, division or unit of an acquiring entity in connection with a change in control, nor a
change in title or Executive&rsquo;s reporting relationships will be deemed a &ldquo;material reduction&rdquo; in and of itself; provided,
however, that, any such termination by Executive shall only be deemed for Good Reason pursuant to this definition if: (1) Executive gives
the Company written notice of his intent to terminate for Good Reason within thirty (30) days following the first occurrence of the condition(s)
that he believes constitute(s) Good Reason, which notice shall describe such condition(s); (2) the Company fails toremedy such condition(s)
within thirty (30) days following receipt of the written notice (the </FONT><B><I>&ldquo;Cure Period&rdquo;); </I></B><FONT STYLE="font-size: 10pt">(3)
the Company has not, prior to receiving such notice from Executive, already informed Executive that his employment with the Company is
being terminated; and (4) Executive voluntarily terminates his employment within thirty (30) days following the end of the Cure Period.
Executive acknowledges that the changes in the terms of his employment contained in this Agreement, relative to the terms of his employment
contained in the Prior Agreement, do not constitute Good Reason under the Prior Agreement, this Agreement or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.1pt; text-align: justify; text-indent: 101.85pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><FONT STYLE="font-size: 10pt">For purposes of this Agreement, </FONT><B><I>&ldquo;Cause&rdquo; </I></B><FONT STYLE="font-size: 10pt">for
termination shall mean that Executive has engaged in any of the following: (i) a material breach of any covenant or condition under this
Agreement or any other material agreement between the parties; (ii) any act constituting dishonesty, fraud, immoral or disreputable conduct;
(iii) any conduct which constitutes a felony under applicable law; (iv) material violation of any Company policy; (v) refusal to follow
or implement a clear, lawful and reasonable directive of Company; (vi) gross negligence or incompetence in the performance of Executive&rsquo;s
duties after the expiration of ten (10) days without cure after written notice of such failure; or (vii) breach of fiduciary duty to
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.45pt; text-align: justify; text-indent: 101.5pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT>The CIC Acceleration provided to Executive pursuant to this Section 6.2 is in lieu of, and not in addition to, any benefits
to which Executive may otherwise be entitled under any Company severance plan, policy, or program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.45pt; text-align: justify; text-indent: 101.5pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><FONT STYLE="font-size: 10pt">Any damages caused by the termination of Executive&rsquo;s employment without Cause in connection
with a Change in Control would be difficult to ascertain; therefore, the</FONT> CIC Acceleration for which Executive is eligible pursuant
to Section 6.2(a) above in exchange for the Separation Agreement is agreed to by the parties as liquidated damages, to serve as full
compensation, and not a penalty.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7pt; text-align: justify; text-indent: 102.2pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><FONT STYLE="font-size: 10pt">If </FONT>the Company terminates Executive&rsquo;s employment without Cause or Executive resigns
for Good Reason outside of the CIC Measurement Period, the Company terminates Executive for Cause at any time, or Executive resigns from
employment without Good Reason at any time, then Executive shall be entitled to the Accrued Obligations, but Executive will not receive
the CIC Acceleration, or any other severance compensation or benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.35pt; text-align: justify; text-indent: 68.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #222222"><B>6.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><FONT STYLE="color: #222222"><U>Cooperation
With the Company After Termination of Employment</U></FONT><FONT STYLE="color: #090909">.</FONT></B> <FONT STYLE="color: #222222">Following
termination of Executive&rsquo;s employment for any reason, Executive shall reasonably cooperate with the Company in all matters relating
to the winding up of Executive&rsquo;s pending work including, but not limited to, any litigation in which the Company is involved, and
the orderly transfer of any such pending work to such other executives as may be designated by the Company</FONT><FONT STYLE="color: #090909">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.1in; text-align: justify; text-indent: 68.25pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>Effect
of Termination.</U></B> Executive agrees that should Executive&rsquo;s employment be terminated for any reason, Executive shall be deemed
to have resigned from any and all positions with the Company, and all positions with any and all subsidiaries and Affiliates of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; color: #222222; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 75.45pt"></TD><TD STYLE="width: 33.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.5</B></FONT></TD><TD STYLE="text-align: left"><U>Application
                                            of Section 409A.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.45pt; text-align: justify; text-indent: 102pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #222222"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><FONT STYLE="color: #222222">It is intended that all of the compensation payable under this Agreement, to the greatest extent
possible, either complies with the requirements of Section 409A of the Internal Revenue Code of </FONT><FONT STYLE="color: #414141">1</FONT><FONT STYLE="color: #222222">986,
as amended (the <B><I>&ldquo;Code&rdquo;) </I></B>and the regulations and other guidance thereunder and any state law of similar effect
(collectively, <B><I>&ldquo;Section 409A&rdquo;) </I></B>or satisfies one or more of the exemptions from the application of Section 409A,
and this Agreement will be construed in a manner consistent with such intention, incorporating by reference all required definitions
and payment terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 6.95pt; text-align: justify; text-indent: 102.25pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT>No severance payments will be made under this Agreement unless Executive&rsquo;s termination of employment constitutes a Separation
from Service. For purposes of Section 409A (including, without limitation, for purposes of Treasury Regulations Section l .409A- 2(b)(2)(iii)),
Executive&rsquo;s right to receive any installment payments under this Agreement (whether severance payments or otherwise) shall be treated
as a right to receive a series of separate payments and, accordingly, each installment payment hereunder shall at all times be considered
a separate and distinct payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 6.95pt; text-align: justify; text-indent: 102.25pt; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 6.95pt; text-align: justify; text-indent: 102.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #222222"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><FONT STYLE="color: #222222">To the extent that any severance payments are deferred compensation under Section 409A, and are
not otherwise exempt from the application of Section 409A, then, to the extent required to comply with Section 409A, if the period during
which Executive may consider and sign the Separation Agreement spans two calendar years, the severance payments will not begin until
the second calendar year</FONT><FONT STYLE="color: #090909">. </FONT><FONT STYLE="font-size: 10pt; color: #222222">If </FONT><FONT STYLE="color: #222222">the
Company determines that the severance benefits provided under this Agreement constitutes &ldquo;deferred compensation&rdquo; under Section
409A and if Executive is a &ldquo;specified employee&rdquo; of the Company, as such term is defined in Section 409A(a)(2)(B)(i) of the
Code at the time of Executive&rsquo;s Separation from Service, then, solely to the extent necessary to avoid the i<FONT STYLE="font-size: 10pt">ncurrence
of the adverse personal tax consequences under Section 409A, the timing of the severance will be delayed as follows: on the earlier to
occur of (a) the date that is six months and one day after Executive&rsquo;s Separation from Service, and (b) the date of Executive&rsquo;s
death, the Company will</FONT></FONT><FONT STYLE="font-size: 10pt; color: #070707">:</FONT> <FONT STYLE="font-size: 10pt; color: #222222">(i)
pay to Executive a lump sum amount equal to the sum of the severance benefits that Executive would otherwise have received if the commencement
of the payment of the severance benefits had not been delayed pursuant to this Section 6.6(c); and (ii) commence paying the balance of
the severance benefits </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #222222">in accordance with the applicable
payment schedule set forth in Sections 6.2 and 6.3</FONT><FONT STYLE="color: #070707">.</FONT> <FONT STYLE="color: #222222">No interest
shall be due on any amounts deferred pursuant to this Section 6</FONT><FONT STYLE="color: #070707">.</FONT><FONT STYLE="color: #222222">6(c)
</FONT><FONT STYLE="color: #070707">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.1in; text-align: justify; text-indent: 101.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #222222"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><FONT STYLE="color: #222222">To the extent required to avoid accelerated taxation and/or tax penalties under Section 409A,
amounts reimbursable to Executive under this Agreement shall be paid to Executive on or before the last day of the year following the
year in which the expense was incurred and the amount of expenses eligible for reimbursement (and in-kind benefits provided to Executive)
during any one year may not effect amounts reimbursable or provided in any subsequent year</FONT><FONT STYLE="color: #070707">. </FONT><FONT STYLE="color: #222222">The
Company makes no representation that compensation paid pursuant to the terms of this Agreement will be exempt from or comply with Section
409A and makes no undertaking to preclude Section 409A from applying to any such payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; color: #222222; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 75.35pt"></TD><TD STYLE="width: 33.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.6</B></FONT></TD><TD STYLE="text-align: left"><U>Excise
                                            Tax Adjustment.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.1in; text-align: justify; text-indent: 102.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #222222"><B><I>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</I></B></FONT><FONT STYLE="font-size: 10pt; color: #222222">If any payment or benefit Executive will or may receive from the Company
or otherwise (a </FONT><FONT STYLE="color: #222222"><B><I>&ldquo;280G Payment&rsquo;) </I></B><FONT STYLE="font-size: 10pt">would (i)
constitute a &ldquo;parachute payment&rdquo; within the meaning of Section 280G of the Code, and</FONT></FONT> <FONT STYLE="font-size: 10pt; color: #363636">(ii)
</FONT><FONT STYLE="font-size: 10pt; color: #222222">but for this Section, be subject to the excise tax imposed by Section 4999 of the
Code (the </FONT><FONT STYLE="color: #222222"><B><I>&ldquo;Excise </I></B></FONT><B><I><FONT STYLE="color: #363636">Tax&rdquo;), </FONT></I></B><FONT STYLE="font-size: 10pt; color: #222222">then
any such 280G Payment provided pursuant to this Agreement (a </FONT><FONT STYLE="color: #222222"><B><I>&ldquo;Payment&rsquo;) </I></B><FONT STYLE="font-size: 10pt">shall
</FONT></FONT><FONT STYLE="font-size: 10pt; color: #363636">be </FONT><FONT STYLE="font-size: 10pt; color: #222222">equal to the Reduced
Amount. The </FONT><FONT STYLE="color: #222222"><B><I>&ldquo;Reduced Amount&rsquo; </I></B><FONT STYLE="font-size: 10pt">shall be either
(x) the largest portion of the Payment that would result in no portion of the Payment (after reduction) being subject to the Excise Tax,
or (y) the largest portion, up to and including the total, of the Payment, whichever amount (i.e., the amount determined by clause (x)
or by clause (y)), after taking into account all applicable federal, state, and loca</FONT></FONT><FONT STYLE="font-size: 10pt; color: #070707">l
</FONT><FONT STYLE="font-size: 10pt; color: #222222">employment taxes, income taxes, and the Excise Tax (all computed at the highest
applicable marginal rate), results in Executive&rsquo;s receipt, on an after-tax basis, of </FONT><FONT STYLE="font-size: 10pt; color: #363636">the
</FONT><FONT STYLE="font-size: 10pt; color: #222222">greater economic benefit notwithstanding that all or some portion of the Payment
may be subject to the Excise </FONT><FONT STYLE="font-size: 10pt; color: #363636">Tax. </FONT><FONT STYLE="font-size: 10pt; color: #222222">If
a reduction in a Payment is required pursuant to the preceding sentence and the Reduced Amount is determined pursuant to clause (x) of
the preceding sentence, the reduction shall occur in the manner (the </FONT><FONT STYLE="color: #222222"><B><I>&ldquo;Reduction Method&rdquo;)
</I></B><FONT STYLE="font-size: 10pt">that resultsin the greatest economic benefit for Executive</FONT></FONT><FONT STYLE="font-size: 10pt; color: #070707">.
</FONT><FONT STYLE="font-size: 10pt; color: #222222">If more than one method of reduction will result in the same economic benefit, the
items so reduced will be reduced pro rata (the </FONT><FONT STYLE="color: #222222"><B><I>&ldquo;Pro Rata Reduction Method&rdquo;).</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.45pt; text-align: justify; text-indent: 102.2pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT>Notwithstanding any provision of this Section 6.7 to the contrary, if the Reduction Method or the Pro Rata Reduction Method
would result in any portion of the Payment being subject to taxes pursuant to Section 409A that would not otherwise be subject to taxes
pursuant to Section 409A, then the Reduction Method and/or the Pro Rata Reduction Method, as the case may be, shall be modified so as
to avoid the imposition of taxes pursuant to Section 409A as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.45pt; text-align: justify; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 10.2pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #222222">(A)&nbsp;
</FONT><FONT STYLE="font-size: 10pt; color: #222222">as a first priority, the modification shall preserve to the greatest extent possible,
the greatest economic benefit for Executive as determined on an after-tax basis; (B) as a second priority, Payments that are contingent
on future events <FONT STYLE="font-family: Times New Roman, Times, Serif"><I>(e.g.,</I></FONT> being terminated without Cause), shall
be reduced (or eliminated) before Payments that are not contingent on future events; and (C) as a third priority,</FONT> <FONT STYLE="color: #282525">Payments
that are &ldquo;deferred compensation&rdquo; within the meaning of Section 409A shall be reduced (or eliminated) before Payments that
are not deferred compensation within the meaning of Section 409A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 10.2pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: #282525">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 10.2pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 10.2pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: #282525">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9.95pt; text-align: justify; text-indent: 102.35pt; color: #282525"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT>Unless Executive and the Company agree on an alternative accounting firm or law firm, the accounting firm engaged by the Company
for general tax compliance purposes as of the day prior to the effective date of the Change in Control transaction shall perform the
foregoing calculations. If the accounting firm so engaged by the Company is serving as accountant or auditor for the individual, entity,
or group effecting the Change in Control transaction, the Company shall appoint a nationally-recognized accounting or law firm to make
the determinations required by this Section 6.7. The Company shall bear all expenses with respect to the determinations by such accounting
or law firm required to be made hereunder. The Company shall use commercially reasonable efforts to cause the accounting or law firm
engaged to make the determinations hereunder to provide its calculations, together with detailed supporting documentation, to Executive
and the Company within fifteen (15) calendar days after the date on which Executive&rsquo;s right to a 280G Payment becomes reasonably
likely to occur (if requested at that time by Executive or the Company) or such other time as requested by Executive or the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 10.2pt; text-align: justify; text-indent: 102.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #282525"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><FONT STYLE="font-size: 10pt; color: #282525">If </FONT><FONT STYLE="color: #282525">Executive receives a Payment for which
the Reduced Amount was determined pursuant to clause (x) of Section 6.7(a) and the Internal Revenue Service determines</FONT> <FONT STYLE="color: #3a3a3a">thereafter
</FONT><FONT STYLE="color: #282525">that some portion of the Payment is subject to the Excise Tax, Executive agrees to promptly return
to the Company a sufficient amount of the Payment (after reduction pursuant to clause (x) of Section 6.7(a)) so that no portion of the
remaining Payment is subject to the Excise Tax. For the avoidance of doubt, if the Reduced Amount was determined pursuant to clause (y)
of Section 6.7(a), Executive shall have no obligation to return any portion of the Payment pursuant to the preceding sentence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #202020"><TR STYLE="vertical-align: top">
<TD STYLE="width: 41.75pt"></TD><TD STYLE="width: 33.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>7.</B></FONT></TD><TD STYLE="text-align: left"><B><U>GENERAL
                                            PROVISIONS.</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.1in; text-align: justify; text-indent: 68.25pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #282525"><B>7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="font-size: 10pt; color: #282525"><U>Notices.</U></FONT></B> <FONT STYLE="color: #282525">Any notices required
hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when
sent by electronic mail or confirmed facsimile if sent during normal business hours of the recipient, and if not, then on the next business
day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one
(1) day after deposit with a nationally- recognized overnight courier, specifying next-day delivery, with written verification of receipt.
All communications shall be sent to the Company at its primary office location and to Executive at Executive&rsquo;s address as </FONT><FONT STYLE="color: #3a3a3a">listed
</FONT><FONT STYLE="color: #282525">on the Company payroll or (if notice is given prior to Executive&rsquo;s termination of employment)
to Executive&rsquo;s Company-issued email address, or at such other address as the Company or Executive may designate by ten (10) days&rsquo;
advance written notice to the other.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.1in; text-align: justify; text-indent: 68.25pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="font-size: 10pt; color: #282525"><U>Severability</U></FONT></B><B><FONT STYLE="font-size: 10pt; color: #535353">.
</FONT></B><FONT STYLE="color: #282525">Whenever possible, each provision of this Agreement will be interpreted in such manner as to
be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal, or unenforceable
in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality, or unenforceability will not affect
any other provision or any other jurisdiction, but this Agreement will be reformed, construed, and enforced in such jurisdiction as if
such invalid, illegal, or unenforceable provisions had never been contained herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.1in; text-align: justify; text-indent: 68.25pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><U>Waiver.</U></B> If either party should waive any breach of any provisions of this Agreement, Executive or the Company
shall not thereby be deemed to have waived any preceding or succeeding breach of the same or any other provision of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.1in; text-align: justify; text-indent: 68.25pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #282828"><B>7.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="color: #282828"><U>Complete Agreement.</U></FONT></B><FONT STYLE="color: #282828"> This Agreement (including
Exhibits A, B and C), and any other separate agreement relating to equity awards constitute the entire agreement between Executive and
the Company with regard to the subject matter hereof and supersede any prior oral discussions or written communications and agreements,
including the Prior Agreement. This Agreement is entered into without reliance on any promise or representation other than those expressly
contained herein, and it cannot be modified or amended except in writing signed by Executive and an authorized officer of the Company</FONT><FONT STYLE="color: #0e0e0e">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.1in; text-align: justify; text-indent: 68.25pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><U>Counterparts.</U></B> This Agreement may be executed by electronic transmission and in separate counterparts, any one
of which need not contain signatures of more than one party, but all of which taken together will constitute one and the same Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.1in; text-align: justify; text-indent: 68.25pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #282828"><B>7.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="color: #282828"><U>Headings</U></FONT><FONT STYLE="color: #464646">.</FONT></B> <FONT STYLE="color: #282828">The
headings of the sections hereof are inserted for convenience only and shall not be deemed to constitute a part hereof nor to affect the
meaning thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.1in; text-align: justify; text-indent: 68.25pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><U>Successors and Assigns.</U></B> The Company shall assign this Agreement and its rights and obligations hereunder in
whole, but not in part, to any company or other entity with or into which the Company may hereafter merge or consolidate or to which
the Company may transfer all or substantially all of its assets, if in any such case said company or other entity shall by operation
of law or expressly in writing assume all obligations of the Company hereunder as fully as if it had been originally made a party hereto,
but may not otherwise assign this Agreement or its rights and obligations hereunder. Executive may not assign or transfer this Agreement
or any rights or obligations hereunder, other than to Executive&rsquo;s estate upon Executive&rsquo;s death.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.1in; text-align: justify; text-indent: 68.25pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #282828"><B>7.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="color: #282828"><U>Choice of Law</U></FONT><FONT STYLE="color: #0e0e0e">.</FONT></B> <FONT STYLE="color: #282828">All
questions concerning the construction, validity, and interpretation of this Agreement will be governed by the laws of the Commonwealth
of Massachusetts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.1in; text-align: justify; text-indent: 68.25pt; color: #222222"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #282828"><B>7.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT><B><FONT STYLE="color: #282828"><U>Resolution of Disputes</U></FONT><FONT STYLE="color: #5b5b5b">. </FONT></B><FONT STYLE="color: #282828">To
ensure the timely and economical resolution of disputes that may arise in connection with Executive&rsquo;s employment with the Company,
Executive and the Company agree that any and all disputes, claims, or causes of action arising from or relating to the enforcement, breach,
performance, negotiation, execution, or interpretation of this Agreement, or Executive&rsquo;s employment, or the termination of Executive&rsquo;s
employment, including but not limited to all statutory claims</FONT><FONT STYLE="color: #464646">, </FONT><FONT STYLE="color: #282828">will
be resolved pursuant to the Federal Arbitration Act, 9 U.S.C</FONT><FONT STYLE="color: #0e0e0e">. </FONT><FONT STYLE="color: #282828">&sect;1-16,
and to the fullest extent permitted by law, by final, binding and confidential arbitration by a single arbitrator conducted in Boston,
Massachusetts by Judicial Arbitration and Mediation Services Inc</FONT><FONT STYLE="color: #464646">.</FONT> <FONT STYLE="color: #282828">(&ldquo;JAMS&rdquo;)
under the then applicable JAMS rules (at the following web address: https://www.jamsadr.com/rules-employment-arbitration/). A hard copy
of the rules will be provided to Executive upon request. <B>By agreeing to this arbitration procedure, both Executive and the Company
waive the right to resolve any such dispute through a trial by jury or judge or administrative proceeding. </B>In addition, all claims,
disputes </FONT><FONT STYLE="color: #464646">, </FONT><FONT STYLE="color: #282828">or causes of action under this provision, whether
by Executive or the Company, must be brought in an individual capacity, and shall not be brought as a plaintiff (or claimant) or class
member in any purported class or representative proceeding, nor joined or consolidated with the claims of any other person or entity.
The arbitrator </FONT>may not consolidate the claims of more than one person or entity, and may not preside over any form of representative
or class proceeding<FONT STYLE="color: #050505">.</FONT> <FONT STYLE="color: #222222">To the extent that the preceding sentences regarding
class claims or proceedings are found to violate applicable law or are otherwise found unenforceable, any claim(s) alleged or brought
on behalf of a class shall proceed in a court of law rather than by arbitration</FONT><FONT STYLE="color: #050505">. </FONT><FONT STYLE="color: #222222">The
Company acknowledges that Executive will have the right to be represented by legal counsel at any arbitration proceeding. Questions of
whether a claim is subject to arbitration under this Agreement shall be decided by the arbitrator. Likewise, procedural questions which
grow out of the dispute and bear on the final disposition are also matters for the arbitrator. The arbitrator shall</FONT><FONT STYLE="color: #050505">:
(a)</FONT> <FONT STYLE="color: #222222">have the authority to compel adequate discovery for the resolution of the dispute and to award
such relief as would otherwise be permitted by law; (b) issue a written arbitration decision, to include the arbitrator&rsquo;s essential
findings and conclusions and a statement of the award; (c) be authorized to award any or all remedies that Executive or the Company would
be entitled to seek in a court of law; and (d) is authorized to award attorneys&rsquo; fees to the prevailing party. Subject to the foregoing
sentence, Executive and the Company shall equally share all <FONT STYLE="font-size: 10pt"><B>JAMS </B></FONT>arbitration fees and each
party is responsible for its own attorneys&rsquo; fees. Nothing in this Agreement is intended to prevent either Executive or the Company
from obtaining </FONT><FONT STYLE="color: #383838">injunctive </FONT><FONT STYLE="color: #222222">relief in court to prevent irreparable
harm pending the conclusion of any such arbitration. Any awards or orders in such arbitrations may be entered and enforced as</FONT>
<FONT STYLE="color: #383838">judgments </FONT><FONT STYLE="color: #222222">in the federal and state courts of any competent jurisdiction</FONT><FONT STYLE="color: #050505">.
</FONT><FONT STYLE="color: #222222">To the extent applicable </FONT><FONT STYLE="color: #383838">law </FONT><FONT STYLE="color: #222222">prohibits
mandatory arbitration of sexual </FONT><FONT STYLE="color: #383838">harassment </FONT><FONT STYLE="color: #222222">claims, in the event
Executive intends to bring multiple claims, including a sexual </FONT><FONT STYLE="color: #383838">harassment </FONT><FONT STYLE="color: #222222">claim,
the sexual harassment claim may be publicly filed with a court, while any other claims will remain subject to</FONT> <FONT STYLE="color: #383838">mandatory
</FONT><FONT STYLE="color: #222222">arbitration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #222222"><I>[Remainder
of page intentionally left blank.]</I></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 11.4pt; text-indent: -0.5pt; color: #2b2b2b"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">IN
</FONT><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>WITNESS WHEREOF&nbsp;</B></FONT><B><FONT STYLE="font-size: 10pt">,
</FONT></B>the parties have executed this Amended and Restated Employment Agreement on the day and year first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: center">&nbsp;</TD>
  <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #2b2b2b">IMMUNOME</FONT><FONT STYLE="color: #4f4f4f">,
  </FONT><FONT STYLE="color: #2b2b2b">INC</FONT><FONT STYLE="color: #4f4f4f">.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: center">&nbsp;</TD>
  <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 3%">By:</TD>
                                <TD STYLE="border-bottom: Black 1pt solid; width: 47%"><I>/s/ Purnand Sarma, PhD</I>&#9;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD>
               <TD>Purnanand Sarma, PhD</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and President </FONT></TD></TR>

<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2">EXECUTIVE:</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><I>/s/ Michael J. Morin, PhD</I></TD></TR>

<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2">Michael J. Morin, PhD</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #2c2c2c; text-align: center"><B><U>Exhibit
A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #222222"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #222222"><B>DUTIES</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">Provide
                                            advice and input to the Company&rsquo;s research and development team with regard to the
                                            Company&rsquo;s ongoing and future programs.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Identify
                                            and evaluate partnering and collaboration opportunities and participate in outreach to potential
                                            partners and collaborators, working closely with the Company&rsquo;s business development/corporate
                                            development team.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">Analyze
                                            information regarding market opportunities, competitors and technology trends and consult
                                            with the Company regarding the same.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Assist
                                            the Company in the development of presentations and marketing materials regarding the Company,
                                            its platform and products, including presentations to potential partners and financing sources.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD COLSPAN="3" STYLE="text-align: justify">Attend
                                            industry and investor conferences/events and the like on the Company&rsquo;s behalf, present
                                            at such conferences/events, participate in one-on-one meetings during any conferences/events
                                            and assist/participate in follow-up meetings.</TD></TR><TR STYLE="vertical-align: top">
<TD STYLE="border-bottom: Black 1pt solid; width: 0.25in">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; width: 0.25in">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; width: 0.35in">&nbsp;</TD>
                              <TD STYLE="border-bottom: Black 1pt solid; width: 0.35in">&nbsp;</TD>
                              <TD>&nbsp;</TD></TR>
                                                                                                                                                    </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 134.2pt; color: #2c2c2c; text-align: center"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 134.2pt; color: #2c2c2c; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #2c2c2c; text-align: center"><B><U>Exhibit
B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.95pt; color: #2c2c2c">EMPLOYEE
CONFIDENTIAL INFORMATION AND INVENTIONS ASSIGNMENT AGREEMENT</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #222222; text-align: center"><B><U>Exhibit
C</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #222222"><B>BUSINESS
AND PROFESSIONAL ACTIVITIES</B></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="text-align: left">Teaching
                                            engagement at University of Massachusetts, Lowell</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>immu-20210801.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaKKWbOdzZR+OYkxtmBxbak6byIitFFMXShftZTWQQID -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:immu="http://immunome.com/20210801" elementFormDefault="qualified" targetNamespace="http://immunome.com/20210801">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://immunome.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="immu-20210801_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="immu-20210801_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>immu-20210801_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>immu-20210801_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://immunome.com/role/Cover" xlink:href="immu-20210801.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://immunome.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>tm2124229d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="immu-20210801.xsd" xlink:type="simple"/>
    <context id="From2021-08-01to2021-08-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001472012</identifier>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-08-01to2021-08-01">0001472012</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-08-01to2021-08-01">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-08-01to2021-08-01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-08-01to2021-08-01">2021-08-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-08-01to2021-08-01">Immunome, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-08-01to2021-08-01">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-08-01to2021-08-01">001-39580</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-08-01to2021-08-01">77-0694340</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-08-01to2021-08-01">665 Stockton Drive, Suite 300</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2021-08-01to2021-08-01">Exton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-08-01to2021-08-01">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-08-01to2021-08-01">19341</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-08-01to2021-08-01">610</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-08-01to2021-08-01">321-3700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-08-01to2021-08-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-08-01to2021-08-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-08-01to2021-08-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-08-01to2021-08-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-08-01to2021-08-01">Common     Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-08-01to2021-08-01">IMNM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-08-01to2021-08-01">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-08-01to2021-08-01">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2021-08-01to2021-08-01">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140469328433656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  01,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Immunome, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001472012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0694340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">665 Stockton Drive, Suite 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Exton<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">321-3700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IMNM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MSYI%K@<7NW2I:CNP06#V\/B D52N'^ ._98V,MV&,9-K?G+EUB#T.%[<C?_
MF"J[#\ZR^VG*]=IEZ2,HV-C92,9D?8%Q0:MSM&Z5V0>X5T_=QIA'Y%'!FZK(
M5\.)C3GDSKJW(B)05]A[%PNY_::A%A9_QLDWQ#O:L;K=_P-SZ3$DX2L0\B\'
MH*OW&^K]B559L8E=*@M;XN(PY@S>7G<#?+]2RKZ=N'UQ^;/&Z#]02P,$%
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " "-A 53F5R<(Q &  "<)P  $P
M            @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M (V$!5/YS4\3700  .(0   8              " @0X(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " "-A 53GZ ;\+$"  #B#   #0
M            @ &A#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( (V$!5.7
MBKL<P    !,"   +              "  7T/  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( (V$!5.JQ"(6,P$  "("   /              "  680  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " "-A 53)!Z;HJT   #X 0  &@
M        @ '&$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " "-A 5399!YDAD!  #/ P  $P              @ &K$@  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #U$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2124229d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://immunome.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2124229d1_8k.htm">tm2124229d1_8k.htm</File>
    <File>immu-20210801.xsd</File>
    <File>immu-20210801_lab.xml</File>
    <File>immu-20210801_pre.xml</File>
    <File>tm2124229d1_ex10-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2124229d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2124229d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "immu-20210801_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "immu-20210801_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "immu-20210801.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "immu",
   "nsuri": "http://immunome.com/20210801",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2124229d1_8k.htm",
      "contextRef": "From2021-08-01to2021-08-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://immunome.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2124229d1_8k.htm",
      "contextRef": "From2021-08-01to2021-08-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://immunome.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001104659-21-100801-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-21-100801-xbrl.zip
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M(<E0NF8(L*K3H\F"XL;N#22FE*-"'PHJES0>!$JM\X.)9M,.224*$)&VLSY
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M '$04 UQ"+R@(X/&3S(*J;#J_IE'GKZQ=$MSS(OY[]S62@$ZM_P -MO<:**
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MF8V;4OB<I=,?#V8/B9]:04FC)*P^48B$RR<6PK@)DQ#E8TLH:90\-20.D?;
MJE*$CT1"UQ_I)H3[Q!3*&R4_#<I#!'ZO6$K49LSB^F'DU!:*'"4K#0M$9#XA
MZU%BM;$9*R8AZ]%[BT C@)*2@N0B!F(D8JF6<N]Q]$!F]ANZ&<@D.-37%(0&
M!257?89TQ-!<)8F%IK=_;IF@W5! *LW!\U%X80C(?%'P>\^#WX/#1\EA:V6^
M*/AGSX-_!H>/DL?6RL2'/[ ?[]1$KCSSWUYC*'B4/+9&(C[V_#ITI^Z5?&+%
M>JTZ]B<EH % 3&_#8O&CL+T1@/3\TA)*'3'5K1:'3_M>:D/X?VQ9=\]9;0\E
MCYCTAH3B/+0L^H![^.%;X'1D J6,DN=6RL$!ZZ*M*/%WY4,+*%:4Y+5*# K5
M6^GF6192!)_TGEI!Z:)DH3Y1. .R6PBMO8/!WFGP&CN4X?98!@K,;XH9Z\=
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MV;DEGK.JKV+?I4 M'ZHV*!]J23:)PC/'1:FJ;(\%(3N'"(0(-"7C8,*9Z_=
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MFV-M0"VPRC5-8'.^4B@&H&]-5:RQMEM# D8EN(=+YMA<D)WP.Z/@<3)7$/8
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M.28<2$B0AK_&0C]APCA9"NRJ/*?-(9J"!V'2PL] /P--LXS/O_]YH.3WCUR
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M="0QF;_QJBH3(\8L.:H>!K<PJL&#[1%=#NXR"":QLI8H18FYW!S Y]P W%-
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M<$3.9>CJ'I)/>)G%;^,"OJ _]L+IQFU<>8(OM"6?@0<W5,6\G_>L&U!BBD[
M:-KZ1/Z"?]ZP^G:S/V]W<'(C2^;\$X39G\5C'\:GMWKSX^BVUKY4*_WLN%'^
MU+$[7SH3M3'X,C;LT>!A\/V;H_;SK7+AJO?WARQ5M<'@[J2ENN7*9_M'T[RE
MY<N6^NGCG3L8EVW/O+YH';1HNV3S_[0JEOB>K?T8[7O*K?-EG.W9C6:VU6;#
M[^7&??8_!>M 48:MR\_C0:?TOM7]=-<X_WX[/"M=-YO6W^7/'KNKW^KG]R?O
MKS^>-\Z^\$X30&%GWSX5/EQWOBG=K_K=_8%9]/:;6JE6:;;M'_UN*U]N7AVX
MSOL[HV^>]OIZ?W+!7*\TO-._J#7/[7WX6[]K9,^^C4X4T_S0'+U[YZ/D_P!0
M2P,$%     @ C80%4Z;?P)PI0P  6G\! !8   !T;3(Q,C0R,CED,5]E>#$P
M+3$N:'1M[7U9<]O6MN8[J_@?T+Z=E%1%T1HLSU=5FI+PE"VY+3FYJ:Y^ (E-
M$3$(\&"0S//K>TU[P$ *E#4ELG4J1R(Q[&'M-:]OO?_M_..'O6[G_6_'^T?P
M_Q[^>W\^./]PO/?^.?\_?/M<OGY_<'KTIW=V_N>'X_]^-D[B_*VWM3G+O?-P
MJC+O1%UYGY.I'_?X@YYWIM)P_ QNA%L_K7K?.V_JIQ=AO)$GL[<>7&X^&"9Y
MGDS+GT5J#$_=?.?EZEN^X4?A1?S6&ZDX5^FSO9_C839[]_[YIX<;2AI>3/)G
M>^\/]HZ_3<)AF'<[6YO]K??/#_8>=%SWO$1-KX8U.3L^/#TY\O8_'I\<'</_
MP^^?C\_.]\^/C[J=XX^?/IS^"5^=>_N_?CX^QM^6K=LPB8+[73R8@5Z_^][.
M-]55_:O(\G \EP_#.%#X\LW^;A@_VSN?A%FWLV2UO:;%]M;RB?)^CH)_%\D[
MF.O[P=[^1:K4%![]_OE@#V?]<TK?KGMAYM&JJ, +XSSQU'BL1GEXJ3P_\Y*Q
MMU]<P B]K5ZWL[VYO=7P[&-SQY&?J^H+>MYP[OEQX U5?J54['T,1Q-?1=Z_
M^M[') UA33]-^D=];ZW\T&]J5.!#J\_K=O!A@^FTB).IZGF#>-1O&-1A,IWY
M\;QZ=_^>#R_1&@Q'DQN/YGX'\:H=R>WL].G*41(EZ5OOO[9W\>>9W8EN!VEE
M.HN2.1 +["HNNJPS$DN89YZYV/L]'"GO4ZJR$!]/%' X"=78.QN%\$$X#D?>
MZ1C^JU)O5J19X<-50']^[/E J &\ N^!!^1 58&\&$D8*$!3LW<5YI/2."SY
M)K%W.LJ3(3S_9<\#VMUD,I$-86+YE(9)ZIG3(61B]FFPMXZ_WS_5/(0$?-7?
M:DDI+_K;,Q2.OYP"LW%&MC'VIV$T?WO=V.C:+/R/XJG4:>Y\ M1F2 O(P-+5
MQ(?_3(N\\*,(OL.="XAND&B PZ>Y'\8PWG2:>1?)I4KC,+X@$K$4A'S-/A&>
MW_/>/\?)E*>D1_5B&W^>[87++M)#C[N=41+'2(1 @?#>5"&1]G",(YB1BC.@
M9^?U8R! \]?/:88$F'DSE69)[$=>IM)+."09WE\Y<'(RABI*KM[A-/3X?E!K
MF5HW=^^67!T6>15F$]XLH((\C N%OP_58L8)5#M+DTM@D]=O.E!VJO(BC8EJ
M-+$;L@**ZWEP+KH=)CUOZ&? L[.9&@&_U:32AM3[3XN47NRVEI%OF@A@?S1*
MT@ 8330'/8FV)$;!E]*>(+O!W6"NA;L]#3.8 F[]"%A4#*(O(WJ!W81=0IZ!
M>A'>,_/3/,1KD=%I<A@G$>PCO.[M0^_/^?[!AV/O\/C#AT_[1T>#DU__^]GF
M,_K[[-/^H?Y;AG85!OD$Q[;Y$Q^J6QRGV9%-_('#?OY9OQ9D0!Z._$AO+3P(
M;=SWYT>5@;W8ZK]B3O'\_&BO_CWL_NOOX22D#&[U60.4XU5^D4N!N.2L/G[9
MLUJ^V/PM_QW\Z9W_!OMS^O'3_LF?\.8OHG_B:Y^??\;_X [>NTK\4.;7R_Z;
MED?]Y>O^SMU*#2*&+5Z)[_\ONGTL71TL5U* I/;SC3_"*/*.C58DY"&$><T3
MO.,V8N1;&XW)R,YL K*KK=P$M@JF@JCQ?KYQ!9,1]9W%7IOQ+=?[] "GRD<E
MLMM1(>ISY6$XRAN0VIPTSS NJ7A&J7,T4!]-(K@:2.;V!HJ*)LC^E,RBI,B]
M0[_(E+<&NF*@QB1;0#:=B6[Z<B5%8-E[M]?4.NL68.[_FB2!]UGYH,ET.XM>
MW=]>"^PM,&(_N/1CL!CC!'AUJR71(_.6#FT?%ADI*O73>;>3JAD8E+#^))=!
MO9K /N"ND54Q1/?$U ^(].RN,ED"*68%*F@JT,0(JI6Q'/O>>>EOSQ S,)>\
M '(@P5V@<L9R'VA!P<?6EM4.DI)E4J5YQ]%1(7J@N2)5)=.FB?"TQ6SLJYYW
M-0E'$UH&F.1HXL<7,,,DCDC?A$.FON&J9=Y5&N8Y#- ..0,&RJM1'K3O!05:
M9P6080HL$!XGIKZH0O+N?K=3'RRY7C/V!<Q+RJU5?. -^J#AYV:+:-1H&JD<
M5628JDMU2&@%\/>4GNS/9A'H!<,(UF*H8J#2'"]0_R["?.[-(C]^4EKP2J+Q
MC@TJ$HW;#R4:/R59B 2SFD \*X9_ :%I'9T]$"X==CMEEM&#ST91@6:#(5%0
M"'IE\Q"OKMF3?)XKA\[QD8 !@5[7T4C-X"1E!1QO?7L 8LR*?&\ QSD(0C8=
MJSR/N")-)LPC8BTE%UX&]]M;D!=Y5TGZE9TM<(HN_4B<+=N[/^'_^<0 VS#W
MC39B!X4G: VCB0)NHS0?R^<SU/:!#]"(8" HC&'1QCC*M=UU+_#GY&#QIK F
M$Y!/ETG.3J0Z,Z()H;'M;DJ#'Q',M(US&L^9C*?!E]CW\*^C(M4N*3UV#[V<
MPPA]!XT. OS;KC1R93(X26(20Z\-O-LQ0_+.S KAL]0W372P!&$2D)=_YH<!
M*2/(J'$E>"V==U*8 ,D@T"S4L$\O\J_JQ,/+"M(..7.1@0H (H1>01(")0F[
MR/B\^..Q'Z9914!XL1K!?2"\\;H@A 4#GL5$"3)IAF;V,(Q"MI$SD4=(_S1(
MGC&-I]M!50BDR52EHY#H(R4EA6:@QGA*Z9S!JL#O4P^&DT^07GD+% HP)'OX
MFPY4]?4_W"J/7:#L/)1 .2J80*PT64HD7EN94_([PC$#]1:HV#@-B5<?J4O0
MLF>DKNEX"]*SW$!'F5B1=CD"%\I)__,D\NWM\RE"HM>RPG?.M'@PQ_ [?0,L
M69XES*C'[K L-_IG@[];9"XJ;Q4ATR.%CGC*4JD@GA]SJN>HUEFF *LR":<]
MF$=)3F.(($.-D^81A*E(8LV'%BWBLJ%L[N)/_;CSSWTY-7?;G[XM.GX/XWM=
M>9AF@/]K8\/[)511\-;[Y%^H=S"*?Q<*9"(,UMO8D/R8]T>#W_5,W/%M;3<,
M\"5^-@31JE+SV4'DC[YZ6S#[+(G"  ;PJ?P\FI>[?.^?PSL;7C\$VORZ,50@
M7V",,QJS.Z27#2/:XE#;2J]T%N8YK@POQB/>TK\+Y=V^?-+N:I1/+VY+/K60
M4M>/Z,O>AV3D-]E!"SPN<F-5#Q1]JLG2#T@NBCY9-HY HH!U%,Y(44-7%O!C
MO&"2L(X*++CO_99< 6-.Z[KG.$VFK&LBER>=,S-!8\D?:'!;N(HG*?[R8N=S
M,W;0OT'8HFDQ43YH^J!M@R!!W?SX6X[&U"<5Q]D\NO3CT%]D9VF?Y]3_JEC
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M_"Q36:8KY_!]!PFJ*/#'$7G7DGKB3H.N@O?4R&H-"<2GQ!QT<2HNF4O&1'#
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M,:XQ]IQ%*#2L?).5!,UK.N-A<B4XXAA8ME+= &[%4XVWZTP@"NB1(4C98W
M8BX[*V& D=['"31<FQ_K!M.H'0Y1_F(?&%PFUH^Y;:N3N9/Q**03J]3//26%
M[Z44RK3TW=Q#-.!."T]/$C<,I'O\:JJC[@N-9875(M/&6NXREG@Y)NU6?;H5
M_7VOFE=0XE)KCH'5U,M]7+FY :G !MXBC[$*/"Q77]M>IVCZ>L])[K&9>K;G
ML^Z]BI8C<)8H*O4N;EZNM:N)JKA=S UN2HU309X3@^=6H'[#^S%^$/(D!:3
M>2:<X9YD@$O;50I2-PS8P6MN0/ <VGI@&HI]%2'#AUAO/S+/NF=]^3:.ZM^
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MK]$K):+HJKXR&CVVA Q!Z284RMUUFXI/<)06M))/2:WE0[TLR2^'C'3W/(N
MT>U$X5?) &?G(#:MM*UE?(E+4()Y"0R\#/J^[I6;U-#UU28UBVY^\(+Z1R9A
M[[*^1\NX>TUZNW8XU]6"R&4NPA*%Z#/'[6Z0_9CM5=SI5WX[?[K+#@GS3XYI
MK0!:TO^=DI2EUMZ.CS\448'3AR=Y>2:SGC(C:RR.BY"L6ACR:T#J()8VG>7$
M0[']I$&T,=H"/! Q%D,"[36I>,N"CZW7<QVE+C=FJ$8VNYU43?V0+,HVD^.2
M4.+UZ%C3H+]!4@SSLN=R)2J8KU,M0GG8=6@2JFB .=A.FUR&B2NZS-EY?4#H
M[Y445TXKP]PXYCYWT?1O$W]NE@_WPJ0-WTT^'''45_W5LM\(:^?7XY/CS_L?
M5LN ^_3Y]/?!V>#TY,R \OS(@'MX,*9&.?NJOW67<K9U2I$>T1<,#('DROHN
M8MMB,#:Y;Y]:1-*-1GWO=JIEXD.R;A E77=<KR Y65L/!!!V?X'=HO;4,VXK
MS86"@8K@J]04)B)L[ER,!1P$1E9Z5'1W11E2&6FW<T\A9$>:Q.$(2"2,!*\?
M-7]$C/)'A/*A4#C0'9(+'B-F?&0;QDT28-*:<0-_#F<AY;Q(T6><Y!(\DI+#
M&(C,W-WM@+(.8QNM>]S@6OI;B_H.<H- -U#'UZ,&JQ7A.M >P@$C3Z/0$4ZA
MIV6*[O!B-&I$YLYR=!2!#,'4;X)R!*T. ]3=#O;9L>6,@:*(DVY0Y%B3GF-.
M)K#F,=D.8#RE(?8&XEI62N#&:6[@(_7N,-:"P<2_Q#/AU$W+B/O=SC[GO$R+
M6+[.+%EDR@I#HX'D'J?PAU.L0DU0&U&4Y:/+'RJEBTU-O/P@H"9>?G/Q7E4Q
MBW +@G9*F>R[:8+@S\&6C[C#UECW!@#=A>C;NCI6@,587] \2UZY$6990?7%
M2.4R4X;RS%TSS%D#=\"ER,^4=E20_\@KX#9!D#>#O1I<<JEBN0."[!R][K%H
M+D],ZHB4V7YD4N:,BFBIG]N\(FE:/VYW!W]*>3O5S*+JF_\ QDQYB0[R%8*<
MU#,?ZK4P5/(*W#3G&A\Z2)(EA2<HH1"B=58B'[J$O0\:>Z@PU&<X7I!W4<*)
MGZA(^\+"F!X)%DP4J0M*O<0.= J[8XT45P9+/H7VP=D>#I5NGE@J54AK4_CV
M+^#I61"*MU%0H>AM%,.5%^J.?,X[:0\M<H0O&%E.MV4[/1=-N/Q"7(X%"T_(
M_5.4:0;1BL6M#,%NA_M(W)1P#-+?F<F2=7.;FE(1.9$)26+;*8M[3#\23G;/
MH/YM@HEOGG P\<V/8.(/D;R*2+XA:'<+8?QE[P\?=7"+R3L8:X1'-I8$C??*
MU[!DY99FY0;/533)19YZC06!4H \F4.W%:C&Z*5W!O(:[=[B^,!(\5]V,"9-
MMB0YELC+IQ$M>#RT7%+NX$=H^[L0IULKFK57(T@]=I0#4\6EB+)ZN>P)WGFE
M1,J4NR# WR0<HN6YW_,.2/\X7.\9O%#=(4%#W9E':&QX/ #H&8'3YU_Y:> V
MC>4X=XR-W1N: 99"]Y5VN!QMO<"6\P:*AUWBC$U/*@N=:@H^(N)2H.3PH>%)
MO0*#,!L5F9QWMZ5UR2BGF>K!93U4--U2H$H7T'YU*;&/4LQ^#*K@T6EXL#Z<
M"R#8,1B "+EQ1Z6FW6F'#;<2-!MUXL9 955'$W],[HU 0R<\()MTB[Q$8&35
MMY&:Y:Y72@#$2P%)WF/=DYI\(>1T2"N074MK_!7^/#7PF4?#IX0O[=ZAS#W$
M(!)8B"!@,RMY*Z= ZI2XPP+3F>.6I(0/H/Y,.[+0L-$L9>0\OZ<A*B@<)2VF
ML9F8SDCU\4[RVA0I WZ62U1(#6"K2R"E!7W#_XIY[S9[@9QSAD_AK3KH27+Y
MA^!]7(+WY4,)WM^4CZ(@NZ[1RXN7^-.JT8L\G/!.)O)X"_TVLODX*-]2=&1D
M*M6=(X!H+U4<<D-8;$IOPPTB#ZQ>6JJ8QY.AGQJS:Y9=&AR&UFG-.5_R@YT_
M)#M_=8?L_ SMD2Q+4FGXD5'7+I>QU_+Q,D%C+7%\UD,D[4K )&U?+B>?+,0.
MEY,$?9*Z#5 8$SGV-#S.R+KHI5,/Y12R&DAMCTU[5U=+1*%C,DN\J4HOE 2_
MR*%"^6)$Z$Z&C'NOZ1^D*W&+(=:-Y9QL)_(#YP@KH% XA6.+@H2=I;$(*D/\
MH443D( /?&%;3,$SQ4UI]+Q2^##+BBECTKOK6=;(G.65IIES]@NB:HAN/G+P
M@5)'U=31G),-?;&2\>8\ 4T7]T/#0-F*LN;]QFUHL=W]2I"%7*?\0-P+O>+E
MAU.>)#EW^>FXC$T/[Y5TY:90D>+^!A18K7]+:*0_)/JCD.BO'\R4GB32Q?R#
M?W5M_[::>7.=6-_'HBN*5A/M C,:87Q9K$GQ]$MPP(8A6"F60(R?+X_87%#(
MVF9P SMQ&<0TB:^4'^43XC4?X?0A1@YPL/QIM:]HZ=S?VGS"WOVMS1_N_<=-
MQ(^=C[]Y*#[^6<'!*C2K/ HS1)>YUD[;'>*/BTEYG>_T/,$""NR9R]! L$9B
M=NGJ8I\0,)S!!#(83OI%-<A/PVK?=]9NKVWYZZI];CN6!?5.IF^$;O&GQ]+#
M9-]PR@DS5#)",D,*BW!\5",DB)BN=Y>=N!11YD )QS%@,%*(Y!/T2JPN$E"=
M6;))JTUIM7N=9"MW$FY8B9X.R5S7$M5M/-QS0)WJ#4BY_R&,J,B3="Z+T\;"
M[UV7M4]4@[):BJ\SZE]:2X+^A3&=@#4/PURWN!C!J-]X7_IG_<-6:DFKL?R,
M7H5W6QM;+W5C+1X!V@UN$3VN;2[>.\[EF'MC-"#@MU##:02<7(A,!^PD(!P[
M^B&ET6.3'64^9WL,,^8YG^$@R7*@BFZGI)?@K?^"G<(ZI]*"X/L^JH#)2I<?
M9-X@'JWBC%FNL:U)Y?F_]C^>640?#1&L..O123+!ZRC%)//6!,O*(O]>J:%.
M0'OK3?)\EKU]_OSJZJK_ES_-_"#M@ZGXG&[>L)2ZX:SB\_6^MP\V7(H+/9N;
M'@'\0JT"-@+]LMDCN9)];-]V(&S!G&3LV.$L+SQFI )@;;##B<N-JMP%3'B*
MJ=)(;/\E(FUK$ NO@:O2I+C G,L\Q1T=4AH.F<=_%0%;Z7X !SG,:"27BD="
M85*DZ8.]08S+&#(+(?@PYE[=CF&NMW=8FSBB Q%MXK*( $<.9#C9BRN[>MX4
M)#3NTI"60:!@G*))>-O,'QG%O^2^T_<0M,(,)@WG;#PF% -: N @5'<&?V#>
M[51-A^1DX2 3UIV2KY"^K@:;2NO<(S?@7PEC7Y3<)H&5/+SL.H N<6K*6"8/
M!KDY^MT.>HV<(R^+KAT KD>F_-"*][[RX)[@+_-3<![4S/Y2$K^H")9R;MTI
MDC.!IV\GV\Q%=_&G;7>(AOY,S;4LF40N*;K* ]$33ITA<1^G<5(P0[X,DX@B
MK+5L-KS,>F?XAE*.%T=-Z!UKV3J>%G7!>RK$1& D0P5D-J:=E.71V"HT(H9S
MPQ1H*GS"=\->&F\+\G;+.);*)KVJJZ-^@\44)U>1 A91[ZX2Z@*D$@\B"2O;
M+Y(+$^$HJI0I;N$6S^M,3UC-_S&&.J+*Z<YT/B]FI1++?<9R /E C8@YBWUN
M#T;?^Q!^5;B//<-[8;#672">RHLT@:TO3 F:9JP^@;W[J4[")^E,WVIH)206
M/\H23_=PUR7;[B JIY7&W69+WW8[:_YZJ]-B=DJBRUS)0* JF+N-\*4YS6N4
M4,V#'F99D:[.'7<!DPPD_1%C[&J,K++:>V>H:NK,.RJ=H!QRV&"=#.!N*FY;
MIJN667=4E;5S'(T9:T#=SIAUHTPK1W!?9C,+&++3;>]#,WA'Q1)#Y4;?]>P\
M<25S7](ID&K].)1%#L^?,W61<T;\M$RIK_5S+? ]P3KU[VIZ/1BC::Q,'KPW
MEB)*X7>7?A@APR-O<M\[*Q<K&D "KE!A7,;%9@L?&H*SC>BOE)W?U_@Z#O9(
M#7-,1G<G:<!DHOEXG-CM31"5<%+BS/140(]V<A4WS[COG218GG[!P(;5K _;
MP)A: 2 RDDY&6YQ)QO;5,)>2SZ4U&J_Q!YLF_57$G'O=AJ'*F2!3$_?<&5V8
MIA1TIW1J6.@I-M(('->D4*Z6]HQF8)<5%-/89/E0DDV '$9G*3M79B8A0%)C
M2FG-OK:SP.1?-G/4%1FCJ<W$!9])H')9L<HEP2#-C0I#+(A$N)M5W4J@75,G
MTZ@G..*\S6:CV&WS$A >G+6%$+%QX),-ZYX :H7Z#77--J\%8@"%@"B[S=NU
M)T&6G*C+=4WPT2"6,:1BLVD1Y>$L4IZ]4UOF_EV/LZ?;F]%;G">PC!="G15#
MV*<(#=Y(Z[_"-@GW.5*. BSJG&"?3BDIQ3#!Y17Q,A&S:>UHRCV$#^O"OR<?
M:).+O.;8'.S]W\^T^@%:9$#QZ'NV/;])H.#PO6'DQU_[_X_A\QZDRN QQS^V
M[B?JT<;%_Q2C"A4TX'M%9]GJOS"G30<2-C;[Y3C"$']N*8Y &S0X:0D92A]<
M^FGHX\"R*9SHC9$_RTC_^V-P?G)\=N;]\=OQY^/37_0:MBW?>[;7*]77Z8IK
MU+7)>#&YC*SZ268MJA6?.<L@\(ZMJ]Y)E(@-WA=>S)W!".;4V!Q#L'D>*@VA
MPHG: 5X<G'X^.OZ\$/NBU7#:SHZQ+*Y#NX"3VPPSP=+"'O?S(W/UX2E.ZN2_
MGVT_:[I3 "IN/UPF!VCP\>.7D]./QTO]EF/\(=KTEJLX^J$G2P,%^GE6:]"
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ML_QV_O'#WO\'4$L! A0#%     @ C80%4W168IU! P  D0P  !$
M     ( !     &EM;74M,C R,3 X,#$N>'-D4$L! A0#%     @ C80%4\*
M#'( "P  X8<  !4              ( !< ,  &EM;74M,C R,3 X,#%?;&%B
M+GAM;%!+ 0(4 Q0    ( (V$!5.6L*3R5@<  #99   5              "
M :,.  !I;6UU+3(P,C$P.# Q7W!R92YX;6Q02P$"% ,4    " "-A 53A6O:
M4+04   @=@  $@              @ $L%@  =&TR,3(T,C(Y9#%?.&LN:'1M
M4$L! A0#%     @ C80%4Z;?P)PI0P  6G\! !8              ( !$"L
M '1M,C$R-#(R.60Q7V5X,3 M,2YH=&U02P4&      4 !0!) 0  ;6X

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
